CLCSOTCPharmaceutical PreparationsFiscal year ends December 31
Cell Source, Inc.
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 14, 2026
$0.49−0.00 (-0.01%)
Close on Oct 19, 2026
- Market cap
- $21.99M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.0883 (+22.07%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Mar 31, 2025
Valuation
- Market cap
- $21.99M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$4.72M
- EPS, diluted
- -$0.14
- Book value per share
- -$0.45
- Diluted shares
- 45M
Thirteen years at a glance
Fiscal years 2012 to 2024 and trailing twelve months, USD
Revenue
–
Operating income
-$3.70M
Net income
-$4.72M
EPS, diluted
-$0.14
Free cash flow
–
Reported periodTrailing twelve months